Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Fresenius Medical Care AGFMS +0.13%76 Intrinsic Value: Projected FCF is $59.60 as of Aug. 24, 2026, which is 7847% above its 10-year median of 0.75. GuruFocus rates FMS with a GF Score™ of 76/100 and a GF Value™ of $24.08 (Fairly Valued). The stock has 3 warning signs investors should review. Among 344 Healthcare Providers & Services companies, Fresenius Medical Care AG ranks better than 87.79% on this metric.
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company. The details of how we calculate the intrinsic value of stocks are described in detail here.
The historical rank and industry rank for Fresenius Medical Care AG's Intrinsic Value: Projected FCF or its related term are showing as below:
FMS'
s Price-to-Projected-FCF Range Over the Past 10 Years
Min: 0.31 Med: 0.75 Max: 1.3
Current: 0.39
During the past 13 years, the highest Price-to-Intrinsic-Value-Projected-FCF of Fresenius Medical Care AG was 1.30. The lowest was 0.31. And the median was 0.75.
FMS's Price-to-Projected-FCF is ranked better than 87.79% of 344
companies
in the Healthcare Providers & Services industry
Industry Median: 1.075
vs FMS: 0.39
Fresenius Medical Care AG (NYSE:FMS) Intrinsic Value: Projected FCF Explanation
The growth multiple is capped between 8.35 and 17.74.
Total Stockholders Equity weighting is more art than science and it should always be revisited in more detail when researching a company. Weightings from 0% to 100% to more than 100% are possible. 80% was chosen as a happy median after taking the above ideas into consideration.
Fresenius Medical Care AG's Price-to-Intrinsic-Value-Projected-FCF for today is calculated as
Price-to-Intrinsic-Value-Projected-FCF
=
Share Price
/
Intrinsic Value: Projected FCF
=
23.46
/
57.862334765243
=
0.41
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fresenius Medical Care AG Intrinsic Value: Projected FCF Related Terms
Fresenius Medical Care AG Intrinsic Value: Projected FCF Historical Data
* Premium members only.
The historical data trend for Fresenius Medical Care AG's Intrinsic Value: Projected FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fresenius Medical Care AG Intrinsic Value: Projected FCF Chart
FMS vs HCA, THC, DVA: Intrinsic Value: Projected FCF Comparison
For the Medical Care Facilities subindustry, Fresenius Medical Care AG's Price-to-Projected-FCF, along with its competitors' market caps and Price-to-Projected-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fresenius Medical Care AG Price-to-Projected-FCF vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Fresenius Medical Care AG's Price-to-Projected-FCF distribution charts can be found below:
* The bar in red indicates where Fresenius Medical Care AG's Price-to-Projected-FCF falls into.
Fresenius Medical Care AG Intrinsic Value: Projected FCF Calculation
Since the intrinsic value calculations based on Discounted Cash Flow Intrinsic Value: DCF (FCF Based), or Discounted Earnings Intrinsic Value: DCF (Earnings Based) cannot be applied to companies without consistent revenue and earnings, GuruFocus developed a valuation model based on normalized Free Cash Flow and Book Value of the company.
The details of how we calculate the intrinsic value of stocks are described in detail here.
This method smooths out the free cash flow over the past 6-7 years, multiplies the results by a growth multiple, and adds a portion of Total Stockholders Equity.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Intrinsic Value: Projected FCF of $59.60 mean?
Fresenius Medical Care AG (FMS) has a Intrinsic Value: Projected FCF of $59.60 as of Aug. 24, 2026. Intrinsic Value: Projected FCF is the stock value based on a projected free cash flow model. View historical data on Fresenius Medical Care AG and its competitors. This is 7847% above median its historical median of 0.75. Over the past decade, Fresenius Medical Care AG's Intrinsic Value: Projected FCF has ranged from 0.31 to 1.30. According to the industry distribution chart, Fresenius Medical Care AG ranks #42 out of 344 companies in the Healthcare Providers & Services industry, placing it in the top 12.2%.
Is Fresenius Medical Care AG's Intrinsic Value: Projected FCF too high?
Fresenius Medical Care AG's current Intrinsic Value: Projected FCF of $59.60 is 7847% above median its 10-year median of 0.75. Over the past 10 years, this metric has ranged from a low of 0.31 to a high of 1.30. The Healthcare Providers & Services industry median Intrinsic Value: Projected FCF is 1.08. Fresenius Medical Care AG's value of $59.60 is 5444.2% above this industry median. Based on the distribution chart, Fresenius Medical Care AG ranks #42 out of 344 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Fresenius Medical Care AG has a GF Score™ of 76/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Fresenius Medical Care AG's Intrinsic Value: Projected FCF compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Fresenius Medical Care AG ranks #42 out of 344 companies for Intrinsic Value: Projected FCF. This places Fresenius Medical Care AG in the top 12% of its industry — outperforming the majority of peers. The industry median Intrinsic Value: Projected FCF is 1.08. Fresenius Medical Care AG's value of $59.60 is 5444.2% above this benchmark. Historically, Fresenius Medical Care AG's own Intrinsic Value: Projected FCF has ranged from 0.31 to 1.30 over the past decade. While the company's 10-year median is 0.75 vs. the industry median of 1.08, Fresenius Medical Care AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Intrinsic Value: Projected FCF for a Healthcare Providers & Services company?
The median Intrinsic Value: Projected FCF among Healthcare Providers & Services companies is 1.08, based on 344 companies in the industry. Companies in the top quartile (top 25%) have a Intrinsic Value: Projected FCF significantly above this median, while those in the bottom quartile fall well below. However, Intrinsic Value: Projected FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fresenius Medical Care AG's current Intrinsic Value: Projected FCF of $59.60 is 5444.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Intrinsic Value: Projected FCF mean?
A high Intrinsic Value: Projected FCF can signal that a stock is expensive relative to its fundamentals. Intrinsic Value: Projected FCF is the stock value based on a projected free cash flow model. View historical data on Fresenius Medical Care AG and its competitors. For the Healthcare Providers & Services industry, the median Intrinsic Value: Projected FCF is 1.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fresenius Medical Care AG's current Intrinsic Value: Projected FCF is $59.60, which is 7847% above median its own 10-year median of 0.75. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fresenius Medical Care AG stock overvalued right now?
Based on GuruFocus' analysis, Fresenius Medical Care AG (FMS) is currently considered Fairly Valued. The stock's GF Value™ is $24.08, compared to a current price of $23.46 — trading 2.6% below its estimated fair value. The current Intrinsic Value: Projected FCF is $59.60, which is 7847% above median its 10-year median of 0.75 and 5444.2% above the Healthcare Providers & Services industry median of 1.08. Fresenius Medical Care AG's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Intrinsic Value: Projected FCF calculated?
Intrinsic Value: Projected FCF is calculated from a company's financial statements. For Fresenius Medical Care AG (FMS), the current Intrinsic Value: Projected FCF is $59.60 as of Aug. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fresenius Medical Care AG (FMS) Overvalued in 2026?
Based on GuruFocus' analysis, Fresenius Medical Care AG stock appears to be undervalued.
The current stock price of $23.46 is trading 2.6% below its estimated GF Value™ of $24.08.
GuruFocus considers Fresenius Medical Care AG to be Fairly Valued.
Key valuation signals for FMS:
Intrinsic Value: Projected FCF: $59.60 (7847% above median its 10-year median of 0.75)
GF Value™: $24.08 vs. price of $23.46 (2.6% below fair value)
Industry Position: 5444.2% above the Healthcare Providers & Services median (#42 of 344)
No single metric tells the full story. See the FMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fresenius Medical Care is the largest dialysis company in the world, treating nearly 300,000 patients from about 3,600 clinics worldwide as of December 2025. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.
76GF Score
Get the complete analysis for FMS
Intrinsic Value: Projected FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FMS has been successfully added to your 
